Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?
Cristiano CarusoG CiascaI BaglivoR Di SantoA GasbarriniDavide FirinuDiego BagnascoGiovanni PassalacquaM SchiappoliMarco CaminatiG W CanonicaEnrico HefflerC CrimiR IntravaiaV BasileM MarinoS ColantuonoStefano R Del GiaccoPublished in: Allergy (2024)
Our findings confirmed the role of FLCs in asthma as a potential biomarker in an inflammatory disease characterized by different endotypes and phenotypes. In particular, FLC-κ and FLC-k/FLC-λ ratio could be a qualitative indicator for asthma, while FLC-λ levels could be a quantitative indicator for clinical severity parameters.